PEREGRINE PHARMACEUTICALS INC 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Nov 1, 2016
Insider Transaction Report
Form 4
LYTLE PAUL J
Chief Financial Officer
Transactions
- Other
Common Stock
2016-10-31$0.29/sh+33,783$9,675→ 146,649 total
Footnotes (1)
- [F1]Shares acquired under the issuer's employee stock purchase plan on October 31, 2016.